Skip to content
Screener

CryoPort, Inc. CYRX Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$49.0MBeat by $794.1K
EPS-$0.20Miss by $0.01
Revenue estimate$48.2M
EPS estimate-$0.19
“Our revenue momentum over the past several periods continued into the second quarter, with total revenue reaching $49.0 million. Life Sciences Services revenue grew 15% year-over-year, led by 25% growth in BioStorage/BioServices revenue. Our Life Sciences Products business also generated solid results during the quarter, driven by continued demand for MVE Biological Solutions' industry-leading cryogenic systems and the successful introduction of new and innovative products.”
Jerrell Shelton

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$48.7M
EPS estimate-$0.19

Financials

Q2 2026

Income statement

See full
Revenue$49.0M+7.7%
Gross profit$22.8M+6.8%
Operating income-$10.0M-4.0%
Net income-$8.3M-108%
EPS (diluted)-$0.20-109%

Balance sheet

See full
Cash & equivalents$269.3M+10.6%
Total debt$232.3M+423%
Total equity$490.7M-5.5%
Total assets$756.2M-2.3%

Cash flow

See full
Operating cash flow$1.1M+115%
CapEx$9.1M+109%
Free cash flow-$8.0M+31.8%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$836.22M+88.3%
Enterprise value$799.26M+226%
P/E10.1×—
P/S4.5×+1.8×

Profitability

See full
Gross margin47.1%+0.8pp
Operating margin-21.2%-3.2pp
FCF margin-10.7%-3.4pp

Returns & leverage

See full
Debt / equity0.5×+0.4×
Current ratio2.1×-14.2×

Segments

By geography

See full
Americas$36.9M+11.0%
EMEA$8.0M+37.7%
Asia Pacific$4.0M-36.6%

By segment

See full
Life Sciences Services$28.7M—
Life Sciences Products$21.5M—

By product

See full
Biologistics Solutions$22.4M+12.5%
Biostorage Bioservices$5.6M+24.8%

FAQ

When did CryoPort, Inc. report Q2 2026 earnings?
CryoPort, Inc. (CYRX) reported Q2 2026 earnings on August 6, 2026 after market close.
What were CryoPort, Inc.'s Q2 2026 revenue and EPS?
CryoPort, Inc. reported revenue of $49.0M and eps of $-0.20 for Q2 2026.
Did CryoPort, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $48.2M by $794.1K. EPS missed the consensus estimate of $-0.19 by $0.01.
How did CryoPort, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.7% from $45.5M a year earlier and eps grew 31.0% from $-0.29.
Where can I find CryoPort, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-092064) and the 10-Q periodic report (0001104659-26-092107) directly on SEC EDGAR. The filing index links above go to sec.gov.